In today's discussion, we highlight some of the basics of non-surgical non-orthopaedic management of knee osteoarthritis (OA). We shall have a future session where we will delve a little into the orthopaedic aspect of osteoarthritis treatment as well.

I can't believe it took us this long to bring forth a topic so common and critical for a cardiology practice. In today's session, we discuss the practical tips and tricks of diagnosing and managing acute pericarditis.

Vericiguat is a newly approved drug for the management of heart failure. Since it's a new class of drug indicated for such, we must familiarize ourselves with the biochemical and clinical properties of this molecule.

One of the essential aspects of clinical cardiology is pre-op cardiac risk stratification for non-cardiac surgery. The very first step in this is to assess the functional status of a patient. For those who can't walk or have limited functional status, pre-op risk stratification often becomes challenging. In this session, we discuss various aspects of such clinical situations.

There could be many reasons for unintentional weight loss, but what triggers concerns is occult malignancy. In this session, we discuss the various aspects of weight loss and preliminary evaluation in the most practical way.

As medical advancements grow, so does the number of pills an average patient takes. Needless to say, polypharmacy is rampant. Once a person takes more than 4 different medicines, we don't know drug to drug interaction of every additional medicine. De-prescribing is a more significant challenge. In this session, we try to address this and our version of how to tackle it.

Dyspepsia, or gastritis or GERD, is one of the most common symptoms in any clinical practice, and we have our ways of managing it. In today's session, we take the help of gastroenterologists and others to discuss a more systematic approach to this omnipresent symptom.

With the advancements in heart failure therapy, it is not unusual to see patients whose Left Ventricular Ejection Fraction improves to near normal with treatment. The challenge comes after that in terms of the treatment strategy. Should the aggressive HF treatment be continued lifelong, or can be de-escalated once LV improves? Let's discuss this.

Monkeypox virus created jitters a few weeks back, and while it seems to be softened now, knowing about the virus will help us prepare for future epidemics. In this session, we learn about the virus, disease pattern, and what can we do to prevent/treat.

Coronary artery disease (CAD) is ubiquitous and often unpredictable. One of the ways cardiologists deal with the probability of having CAD is to 'risk profile' an individual and investigate accordingly. In this session, we discuss how to evaluate for CAD in a person who has an intermediate risk for CAD.